Acceptance and Commitment Therapy for Insomnia
- Conditions
- Insomnia
- Interventions
- Behavioral: Acceptance and Commitment Therapy for InsomniaBehavioral: Cognitive Behavioral Therapy for Insomnia
- Registration Number
- NCT04866914
- Lead Sponsor
- University of Sao Paulo General Hospital
- Brief Summary
Insomnia is a frequent complaint and is associated with impairments in physical and psychological health. Although Cognitive-Behavioral Therapy (CBT) demonstrates effective results for insomnia, there are those who do not respond to this type of intervention or present difficulties in adherence. Acceptance and Commitment Therapy (ACT) presents itself as a potentially useful intervention for the treatment of insomnia, for which, instead of focusing on controlling the symptoms, the respective approach focuses on accepting the feelings and thoughts associated, through value-based actions. The aim of this study is to evaluate the effectiveness of ACT for chronic insomnia in adults. Participants will be 150 adults aged between 18 and 59 years, diagnosed with chronic insomnia who will be randomly assigned to the ACT, CBT and wait list (WL) groups. For both groups (ACT and CBT), the intervention will be performed in six group and weekly sessions. Assessments of sleep patterns, insomnia, depression, anxiety, psychological flexibility, acceptance of sleep, beliefs about sleep, personality traits will be performed in the pre-treatment, post-treatment and six-month follow-up. After the intervention is completed, participants will respond to an inventory of compliance and satisfaction. Treatment effects will assessed using the fixed effects of group variables (ACT vs. CBT-I and ACT vs. waitlist) and their interaction with time (pre-test vs. post-test and pretest vs. six-month follow-up). Estimated pairwise contrasts to examine changes across time within groups will be used. Variables will analyzed using generalized mixed models (GMM).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 227
- Clinical diagnosis of chronic insomnia
- Neurological degenerative disease
- Psychotic disorder
- sleep apnea, restless legs or periodic limb movements during sleep, or a circadian-based sleep disorder (e.g., delayed or advanced sleep phase syndrome)
- cognitive impairments
- unavailability in attending the sessions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ACT for Insomnia Acceptance and Commitment Therapy for Insomnia - CBT for Insomnia Cognitive Behavioral Therapy for Insomnia -
- Primary Outcome Measures
Name Time Method Change in the score of Insomnia Severity Index (ISI) baseline, 7 weeks and 24 weeks after treatment commencement. Change in the total score of Insomnia Severity Index (ISI)
- Secondary Outcome Measures
Name Time Method Increase in Total Sleep Time (TST) baseline, 7 weeks and 24 weeks after treatment commencement. Increase in Total Sleep Time (TST) measured by sleep diary
Reduction in Wake After Sleep Onset (WASO) baseline, 7 weeks and 24 weeks after treatment commencement. Reduction in Wake After Sleep Onset (WASO) measured by sleep diary
Change in the Acceptance and Action Questionnaire-II (AAQ-II) baseline, 7 weeks and 24 weeks after treatment commencement. Change in the the total score of Acceptance and Action Questionnaire-II (AAQ-II)
Change in the Sleep Problem Acceptance Questionnaire (SPAQ) baseline, 7 weeks and 24 weeks after treatment commencement. Change in the the total score of Sleep Problem Acceptance Questionnaire (SPAQ)
Treatment response - categorical variable baseline, 7 weeks and 24 weeks after treatment commencement. change or reduction in the ISI total score of 8 points or more
Increase in Sleep Efficiency (SE) baseline, 7 weeks and 24 weeks after treatment commencement. Increase in Sleep Efficiency (SE) measured by sleep diary
Change in the Hospital Anxiety and Depression Scale (HADS) baseline, 7 weeks and 24 weeks after treatment commencement. Change in the total score for the anxiety variable (HADAS-A) and total score for the depression variable (HADAS-D)
Remission - categorical variable baseline, 7 weeks and 24 weeks after treatment commencement. a final ISI score under 8 points
Reduction in Sleep Onset Latency (SOL) baseline, 7 weeks and 24 weeks after treatment commencement. Reduction in Sleep Onset Latency (SOL) measured by sleep diary
Change in the Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16) baseline, 7 weeks and 24 weeks after treatment commencement. Change in the the total score of Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16)
Trial Locations
- Locations (1)
University of Sao Paulo General Hospital.
🇧🇷São Paulo, Brazil